Human immunodeficiency virus infection among intravenous drug addicts in Israel - stable low prevalence over 34 months

Michael Dan*, Alex Cahana, Yoram Fintsi, Shulamit Bar-shany

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

A serological survey of 300 Israeli intravenous drug addicts in 1988-1989, showed a 2.3% prevalence of antibodies to human immunodeficiency virus (HIV), very similar to the finding of a previous study (2%) performed in the same population in 1986. Travel and drug injection abroad continue to be the most significant predictors of HIV seropositivity in this group. The relatively uncommon use of cocaine and the absence of 'shooting galleries' in Israel, appears to explain best the stable low prevalence of HIV infection among parenteral drug addicts in this country.

Original languageEnglish
Pages (from-to)561-563
Number of pages3
JournalInternational Journal of Epidemiology
Volume21
Issue number3
DOIs
StatePublished - Jun 1992
Externally publishedYes

Funding

FundersFunder number
Ministry of Health, State of Israel

    Fingerprint

    Dive into the research topics of 'Human immunodeficiency virus infection among intravenous drug addicts in Israel - stable low prevalence over 34 months'. Together they form a unique fingerprint.

    Cite this